Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Smit, AK"'
Autor:
Smit, AK, Espinoza, D, Fenton, GL, Kirk, J, Innes, JS, McGovern, M, Limb, S, On Behalf Of The Managing Your Risk Study Group, Turbitt, E, Cust, AE
Personalized polygenic risk information may be used to guide risk-based melanoma prevention and early detection at a population scale, but research on communicating this information is limited. This mixed-methods study aimed to assess the acceptabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::0756cc773c70ff0de36f29b5aba48b47
https://hdl.handle.net/10453/163105
https://hdl.handle.net/10453/163105
Autor:
Steinberg, J, Iles, MM, Lee, JY, Wang, X, Law, MH, Smit, AK, Nguyen-Dumont, T, Giles, GG, Southey, MC, Milne, RL, Mann, GJ, Bishop, DT, MacInnis, RJ, Cust, AE
Background Previous studies suggest polygenic risk scores (PRS) may improve melanoma risk stratification. However, there has been limited independent validation of PRS-based risk prediction, particularly assessment of calibration (comparing predicted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::95bcafddae9bd5296f0996c0c584d2bd
Autor:
Smit, AK, Bartley, N, Best, MC, Napier, CE, Butow, P, Newson, AJ, Tucker, K, Ballinger, ML, Thomas, DM, Jacobs, C, Meiser, B, Goldstein, D, Savard, J, Juraskova, I, PiGeOn authorship group
Objective This study explored family communication about undertaking genomic sequencing, and intentions to communicate pertinent heritable results to family members. Methods Semi-structured interviews were conducted with cancer patients (n = 53) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::c92cd4484f6debefe590363fe3e5aaf3
https://hdl.handle.net/10453/150990
https://hdl.handle.net/10453/150990
Autor:
Best, MC, Butow, P, Jacobs, C, Savard, J, Biesecker, B, Ballinger, ML, Bartley, N, Davies, G, Napier, CE, Smit, AK, Thomas, DM, Newson, AJ, Members of the PiGeOn Project
Implementation of any new medical test, including germline genome sequencing (GS) to inform cancer risk, should take place only when a test is effective, ethically justifiable and acceptable to a population. Little empirical evidence exists on patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::4f6e8aca4ad4e280a0d8dc59c29d0937
https://hdl.handle.net/10453/143221
https://hdl.handle.net/10453/143221
Autor:
Smit, AK, Espinoza, D, Newson, AJ, Morton, RL, Fenton, G, Freeman, L, Dunlop, K, Butow, PN, Law, MH, Kimlin, MG, Keogh, LA, Dobbinson, SJ, Kirk, J, Kanetsky, PA, Mann, GJ, Cust, AE
BACKGROUND: Communication of personalized melanoma genomic risk information may improve melanoma prevention behaviors. METHODS: We evaluated the feasibility and acceptability of communicating personalized genomic risk of melanoma to the public and it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::e5a6e7293f48086df094d161548ae1ae
https://hdl.handle.net/10453/160889
https://hdl.handle.net/10453/160889
Autor:
Melhoranse Gouveia B; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, UNSW, Sydney, New South Wales, Australia., Ferguson PM; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Lo SN; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Collgros H; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Martin LK; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, UNSW, Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Sinz C; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Smit AK; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Gallo B; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Ho G; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; School of Clinical Medicine, Faculty of Medicine & Health, UNSW, Sydney, New South Wales, Australia., Glanz A; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Scolyer RA; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Cust AE; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Guitera P; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Nov 13. Date of Electronic Publication: 2024 Nov 13.
Autor:
Smit AK; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia; The University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, Sydney, NSW, Australia., Gokoolparsadh A; The University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, Sydney, NSW, Australia., McWhirter R; ANU College of Law, Australian National University, Canberra, ACT, Australia., Newett L; National Centre for Indigenous Genomics, Australian National University, Canberra, ACT Australia., Milch V; Cancer Australia, Surry Hills, NSW Australia; Caring Futures Institute, Flinders University, Adelaide, Australia., Hermes A; National Centre for Indigenous Genomics, Australian National University, Canberra, ACT Australia., McInerney-Leo A; Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD Australia., Newson AJ; The University of Sydney, Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, Sydney, NSW, Australia. Electronic address: ainsley.newson@sydney.edu.au.
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2024 Sep 13; Vol. 26 (12), pp. 101270. Date of Electronic Publication: 2024 Sep 13.
Autor:
Smith J; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Espinoza D; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Smit AK; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Gallo B; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Smith AL; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Guitera P; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Martin LK; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Cust AE; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Publikováno v:
The Australasian journal of dermatology [Australas J Dermatol] 2024 Sep; Vol. 65 (6), pp. e156-e163. Date of Electronic Publication: 2024 Jun 07.
Autor:
Perera MM; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Smit AK; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Smith AL; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Gallo B; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Tan I; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Espinoza D; NHMRC Clinical Trials Centre, The Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Laginha BI; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia., Guitera P; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Martin LK; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Cust AE; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Dec 01; Vol. 155 (11), pp. 2058-2067. Date of Electronic Publication: 2024 Aug 23.
Autor:
Zheng L; Centre for Health Services Research, The University of Queensland, St. Lucia, QLD 4067, Australia., Smit AK; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, NSW 2006, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia., Cust AE; The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, NSW 2006, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia., Janda M; Centre for Health Services Research, The University of Queensland, St. Lucia, QLD 4067, Australia.
Publikováno v:
Journal of personalized medicine [J Pers Med] 2024 Aug 14; Vol. 14 (8). Date of Electronic Publication: 2024 Aug 14.